Estelamari Rodriguez

1 month ago | onclive.com | Estelamari Rodriguez |Tarek Mekhail |Balazs Halmos |Susan Scott |Julie R. Brahmer |Corey J Langer | +1 more

CommentaryVideoApril 30, 2025Author(s):,Fact checked by:,Lung cancer experts discuss successes and hesitations regarding the evolving use of antibody-drug conjugates in non–small cell lung cancer.

Jan 6, 2025 | onclive.com | Estelamari Rodriguez

Estelamari Rodriguez, MD, MPH, discusses how to overcome disparities in cancer care. Estelamari Rodriguez, MD, MPH, discusses how to overcome disparities in cancer care.

Feb 2, 2024 | onclive.com | Estelamari Rodriguez

February 2, 2024Estelamari Rodriguez, MD, MPH, discusses adverse effects associated with HER2-directed antibody-drug conjugates in non–small cell lung cancer.